How To Use CPT Code 90672

CPT 90672 describes the administration of an altered form of the influenza virus via the nose to provide immunity against four forms of influenza. This article will cover the description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, similar codes and billing examples.

1. What is CPT Code 90672?

CPT 90672 is used to describe the administration of a live, quadrivalent influenza vaccine through the nose. This vaccine is designed to protect against four strains of the influenza virus that are expected to circulate in a given year. The provider counsels the patient and their family, provides instructions and precautions, and administers the vaccine to protect against influenza.

2. Official Description

The official description of CPT code 90672 is: ‘Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use.’

3. Procedure

1. The patient is appropriately prepped for the administration of the vaccine.
2. The provider administers the live, quadrivalent influenza vaccine into the nose to protect against influenza.
3. The provider counsels the patient and their family, providing instructions and precautions before administering the vaccine.

4. Qualifying circumstances

CPT 90672 is used for patients who require protection against four forms of influenza. This vaccine is typically administered to individuals who are at risk of contracting the influenza virus. It is important to note that the vaccine is administered through the nose, making it suitable for individuals who may have difficulty receiving injections.

5. When to use CPT code 90672

CPT code 90672 should be used when a provider administers the live, quadrivalent influenza vaccine through the nose to protect against four strains of the influenza virus. It is important to ensure that the vaccine is administered according to the appropriate guidelines and recommendations for each influenza season.

6. Documentation requirements

To support a claim for CPT 90672, the provider must document the following information:

• The product administered, including the specific vaccine and its formulation
• The route of administration, which is intranasal in this case
• The purpose of the vaccine, which is to protect against four strains of the influenza virus
• Any relevant counseling or instructions provided to the patient and their family

7. Billing guidelines

When billing for CPT 90672, ensure that the provider administers the live, quadrivalent influenza vaccine through the nose. It is important to follow the appropriate coding guidelines and report separate codes for vaccine administration, the actual vaccine, and any associated office visits. Documentation should clearly explain the product administered, the route of administration, and the purpose of the vaccine.

8. Historical information

CPT 90672 was added to the Current Procedural Terminology system on January 1, 2013. There have been no updates or changes to the code since its addition.

9. Examples

1. A healthcare provider administers the live, quadrivalent influenza vaccine through the nose to a patient to protect against four strains of the influenza virus.
2. A nurse counsels a patient and their family before administering the live, quadrivalent influenza vaccine through the nose to provide immunity against influenza.
3. A pediatrician administers the live, quadrivalent influenza vaccine through the nose to a child to protect against four strains of the influenza virus.
4. A healthcare provider explains the purpose and precautions of the live, quadrivalent influenza vaccine before administering it through the nose to a patient.
5. A pharmacist administers the live, quadrivalent influenza vaccine through the nose to a patient to provide immunity against four strains of the influenza virus.
6. A healthcare provider discusses the benefits and potential side effects of the live, quadrivalent influenza vaccine before administering it through the nose to a patient.
7. A nurse administers the live, quadrivalent influenza vaccine through the nose to a patient and provides instructions on post-vaccine care.
8. A healthcare provider administers the live, quadrivalent influenza vaccine through the nose to a patient and documents the details of the administration.
9. A physician explains the importance of the live, quadrivalent influenza vaccine and administers it through the nose to a patient.
10. A healthcare provider administers the live, quadrivalent influenza vaccine through the nose to a patient and monitors for any adverse reactions.